Jose E. Martinez-Ales - Publications

Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study.

Journal: Breast (Edinburgh, Scotland)

Published: May 24, 2024

Real world data on the demographic and clinicopathological profile and management of patients with early-stage HER2-positive breast cancer and residual disease treated with adjuvant trastuzumab emtansine (KARMA study).

Journal: Cancer treatment and research communications

Published: January 17, 2023

Clinical practice guidelines for BRCA1 and BRCA2 genetic testing.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 23, 2020

Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP).

Journal: Breast (Edinburgh, Scotland)

Published: July 15, 2020

SEOM clinical guidelines in hereditary breast and ovarian cancer (2019).

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 05, 2019

SEOM-SERAM-SEMNIM guidelines on the use of functional and molecular imaging techniques in advanced non-small-cell lung cancer.

Journal: Radiologia

Published: January 10, 2018

Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.

Journal: Targeted oncology

Published: December 16, 2017

A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.

Journal: Targeted oncology

Published: November 13, 2017

SEOM-SERAM-SEMNIM guidelines on the use of functional and molecular imaging techniques in advanced non-small-cell lung cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: November 01, 2017

Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain.

Journal: Psycho-oncology

Published: October 19, 2017

Preventive treatments for breast cancer: recent developments.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: February 20, 2014

Recalibration of the Gail model for predicting invasive breast cancer risk in Spanish women: a population-based cohort study.

Journal: Breast cancer research and treatment

Published: December 11, 2012